Ultrasound and drug research holds promise for Alzheimer's disease

April 5, 2017
Ultrasound and drug research holds promise for Alzheimer's disease
Three dimensional imaging of the blood-brain barrier. Credit: University of Queensland

Non-invasive ultrasound improves the delivery to the brain of a therapeutic antibody targeting Alzheimer's disease, University of Queensland researchers have found.

Scientists from UQ's Queensland Brain Institute (QBI), previously showed non-pharmacological scanning reversed Alzheimer's symptoms and restored memory in mice. 

The new research found that ultrasound alone cleared toxic tau protein clumps, but combining ultrasound with an antibody was more effective than either treatment alone in removing protein clumps and reducing Alzheimer's symptoms in mice.  

QBI director Professor Pankaj Sah said the research was made possible through the support of the State and Federal Governments, and philanthropic support led by the Clem Jones Foundation.

"The discovery is another promising step made by QBI researchers towards future therapeutic treatments for dementia," Professor Sah said.

"Excitingly, the research shows that ultrasound may also be a viable treatment for other disorders in which proteins aggregate in the – including Parkinson's and ." 

Professor Jürgen Götz, the study's leader and Director of QBI's Clem Jones Centre for Ageing Dementia Research (CJCADR), said the combination treatment increased uptake of the therapeutic antibody into the brain and its individual neurons, and could be used to make treatments for brain diseases more cost-effective.

"With vaccination trials in dementia currently ongoing elsewhere, the problem is that only 0.1% of the therapeutic enter the brain, which would make a potential treatment for Alzheimer's very costly," said Professor Götz.

The paper's lead author, Dr Rebecca Nisbet, said antibody therapies could cost an estimated $25,000 to $100,000 per patient per year, and their research could drastically reduce the cost of these treatments.

Delivering drugs to the brain is difficult because of the blood–brain barrier, which protects from toxins in the bloodstream; however, the ultrasound approach temporarily opens the barrier, increasing the uptake of drug treatments and restoring memory functions.

The UQ researchers are conducting ongoing work to translate the research into a therapy for patients in coming years, and in the meantime, patients are being advised to contact their doctors. 

Alzheimer's disease is the most common form of dementia, and the number of cases in Australia is expected to rise to 900,000 by 2050.

Explore further: Research finds that ultrasound slows brain ageing

More information: Combined effects of scanning ultrasound and a tau-specific single chain antibody in a tau transgenic mouse model, Brain (2017). DOI: 10.1093/brain/awx052

Related Stories

Research finds that ultrasound slows brain ageing

October 12, 2016
Treatment with scanning ultrasound has already been proven to reverse Alzheimer's disease in mice, and now it appears it could also slow down ageing in healthy brains, according to University of Queensland research.

Ultrasound against Alzheimer's shows promise in lab animals

March 12, 2015
Queensland scientists have found that non-invasive ultrasound technology can be used to treat Alzheimer's disease and restore memory.

Treatment approach used in cancer holds promise for Alzheimer's disease

October 21, 2016
Researchers have developed a novel treatment that could block the development of Alzheimer's disease using microscopic droplets of fat to carry drugs into the brain. This treatment approach, which is used to target drugs ...

Blood-brain barrier opened noninvasively with focused ultrasound for the first time

November 10, 2015
The blood-brain barrier has been non-invasively opened in a patient for the first time. A team at Sunnybrook Health Sciences Centre in Toronto used focused ultrasound to enable temporary and targeted opening of the blood-brain ...

New research study creates new opportunities for treating brain diseases

January 16, 2017
Immunotherapy has proven to be effective against many serious diseases. But to treat diseases in the brain, the antibodies must first get past the obstacle of the blood-brain barrier. In a new study, a research group at Uppsala ...

New hope for dementia sufferers

February 8, 2013
(Medical Xpress)—Research that aims to rid dementia sufferers' brains of toxins could lead to a new treatment that reverses the symptoms of Alzheimer's disease in the future.

Recommended for you

Genetics study suggests that education reduces risk of Alzheimer's disease

December 7, 2017
The theory that education protects against Alzheimer's disease has been given further weight by new research from the University of Cambridge, funded by the European Union. The study is published today in the BMJ.

Healthy mitochondria could stop Alzheimer's

December 6, 2017
Alzheimer's disease is the most common form of dementia and neurodegeneration worldwide. A major hallmark of the disease is the accumulation of toxic plaques in the brain, formed by the abnormal aggregation of a protein called ...

Alzheimer's damage in mice reduced with compound that targets APOE gene

December 6, 2017
People who carry the APOE4 genetic variant face a substantial risk for developing Alzheimer's disease.

Lithium in water associated with slower rate of Alzheimer's disease deaths

December 5, 2017
Rates of diabetes and obesity, which are important risk factors for Alzheimer's disease, also decrease if there is a particular amount of lithium in the water, says the study, published recently in the Journal of Alzheimer's ...

Hyperbaric oxygen therapy may alleviate symptoms of Alzheimer's Disease

December 5, 2017
A new Tel Aviv University study reveals that hyperbaric oxygen treatments may ameliorate symptoms experienced by patients with Alzheimer's disease.

New Alzheimer's animal model more closely mimics human disease

December 4, 2017
By injecting human Alzheimer's disease brain extracts of pathological tau protein (from postmortem donated tissue) into mice with different amounts of amyloid-β (Aβ) plaques in their brains, researchers from the Perelman ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.